LONDON, December 29, 2017 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced it has...
from PR Newswire: //www.prnewswire.co.uk/news-releases/gw-pharmaceuticals-submits-marketing-authorisation-application-in-europe-for-epidiolex-cannabidiol-in-667118673.html
No comments:
Post a Comment